Gene Flow and Individual Relatedness Suggest Population Spatial Connectivity of Sinogastromyzon sichangensis (Cypriniformes: Balitoridae) in the Chishui River, China

stjosephs-hospital

 

  • Sinogastromyzon sichangensisis a hillstream loach endemic to the upper Yangtze River, China. It is unclear whether this fish lives in a very restricted area or may be dispersed over a long distance. In the present study spatial connectivity of populations of  sichangensis was investigated based on 343 individuals collected from 12 sites of Chishui River and employing 22 microsatellite loci.
  • The results of genetic diversity analysis showed that observed heterozygosity (HO) and polymorphism information content (PIC) ranged from 0.5653 to 0.6999 and 0.8513 to 0.8819, respectively. Population structure analysis suggested that  sichangensishad an unclear genetic structure. AMOVA showed that 69.36% of genetic variation was attributed to differentiation within individuals and all the pairwise genetic differentiation indices (FST) were low (mean FST = 0.0344), indicating weak differentiation among these populations.
  • Estimation of gene flow showed frequent flow among populations, and contemporary levels (mean contemporary migration rate, mc= 0.0131) were approximately equal to historical levels (mean historical migration rate, mh = 0.0147).
  • Individual relatedness analysis revealed a high level of sibship within and among different populations. The frequent gene flow and widespread sibship were due to  sichangensislaying drifting eggs which travel for a long distance until hatching, after which the juveniles or adults migrate upstream. The results of unclear geographic structure and frequent exchange also indicate that it is necessary to decrease the negative impacts of anthropogenic activities on the connectivity of rivers to protect the migration routes of S. sichangensis.

 

Case Report: Identification of a Novel Variant (m.8909T>C) of Human Mitochondrial ATP6 Gene and Its Functional Consequences on Yeast ATP Synthase

 

With the advent of next generation sequencing, the list of mitochondrial DNA (mtDNA) mutations identified in patients rapidly and continuously expands. They are frequently found in a limited number of cases, sometimes a single individual (as with the case herein reported) and in heterogeneous genetic backgrounds (heteroplasmy), which makes it difficult to conclude about their pathogenicity and functional consequences.

As an organism amenable to mitochondrial DNA manipulation, able to survive by fermentation to loss-of-function mtDNA mutations, and where heteroplasmy is unstable, Saccharomyces cerevisiae is an excellent model for investigating novel human mtDNA variants, in isolation and in a controlled genetic context. We herein report the identification of a novel variant in mitochondrial ATP6 gene, m.8909T>C. It was found in combination with the well-known pathogenic m.3243A>G mutation in mt-tRNALeu.

We show that an equivalent of the m.8909T>C mutation compromises yeast adenosine tri-phosphate (ATP) synthase assembly/stability and reduces the rate of mitochondrial ATP synthesis by 20-30% compared to wild type yeast. Other previously reported ATP6 mutations with a well-established pathogenicity (like m.8993T>C and m.9176T>C) were shown to have similar effects on yeast ATP synthase. It can be inferred that alone the m.8909T>C variant has the potential to compromise human health.

Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer

 

  • Endometrial cancer (EC) is the commonest gynaecological malignancy. Current prognostic markers are inadequate to accurately predict patient survival, necessitating novel prognostic markers, to improve treatment strategies. Telomerase has a unique role within the endometrium, whilst aberrant telomerase activity is a hallmark of many cancers.
  • The aim of the current in silico study is to investigate the role of telomere and telomerase associated genes and proteins (TTAGPs) in EC to identify potential prognostic markers and therapeutic targets. Analysis of RNA-seq data from The Cancer Genome Atlas identified differentially expressed genes (DEGs) in EC (568 TTAGPs out of 3467) and ascertained DEGs associated with histological subtypes, higher grade endometrioid tumours and late stage EC.
  • Functional analysis demonstrated that DEGs were predominantly involved in cell cycle regulation, while the survival analysis identified 69 DEGs associated with prognosis. The protein-protein interaction network constructed facilitated the identification of hub genes, enriched transcription factor binding sites and drugs that may target the network.
  • Thus, our in silico methods distinguished many critical genes associated with telomere maintenance that were previously unknown to contribute to EC carcinogenesis and prognosis, including NOP56WFS1ANAPC4and TUBB4A. Probing the prognostic and therapeutic utility of these novel TTAGP markers will form an exciting basis for future research.
stjosephs-hospital

stjosephs-hospital

CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy

 

Cancer immunotherapy has been emerged as a promising strategy for treatment of a broad spectrum of malignancies ranging from hematological to solid tumors. One of the principal approaches of cancer immunotherapy is transfer of natural or engineered tumor-specific T-cells into patients,

a so called “adoptive cell transfer”, or ACT, process. Construction of allogeneic T-cells is dependent on the employment of a gene-editing tool to modify donor-extracted T-cells and prepare them to specifically act against tumor cells with enhanced function and durability and least side-effects. In this context, CRISPR technology can be used to produce universal T-cells, equipped with recombinant T cell receptor (TCR) or chimeric antigen receptor (CAR), through multiplex genome engineering using Cas nucleases.

The robust potential of CRISPR-Cas in preparing the building blocks of ACT immunotherapy has broaden the application of such therapies and some of them have gotten FDA approvals. Here, we have collected the last investigations in the field of immuno-oncology conducted in partnership with CRISPR technology. In addition, studies that have addressed the challenges in the path of CRISPR-mediated cancer immunotherapy, as well as pre-treatment applications of CRISPR-Cas have been mentioned in detail.

Deregulated microRNAs Are Associated with Patient Survival and Predicted to Target Genes That Modulate Lung Cancer Signaling Pathways

 

Background: Although the advances in diagnostic and treatment strategies, lung cancer remains the leading cause of cancer-related deaths, worldwide, with survival rates as low as 16% in developed countries. Low survival rates are mainly due to late diagnosis and the lack of effective treatment. Therefore, the identification of novel, clinically useful biomarkers is still needed for patients with advanced disease stage and poor survival.

Micro(mi)RNAs are non-coding RNAs and potent regulators of gene expression with a possible role as diagnostic, prognostic and predictive biomarkers in cancer.

Methods: We applied global miRNA expression profiling analysis using TaqMan® arrays in paired tumor and normal lung tissues (n = 38) from treatment-naïve patients with lung adenocarcinoma (AD; n = 23) and lung squamous cell carcinoma (SCC; n = 15). miRNA target genes were validated using The Cancer Genome Atlas (TCGA) lung AD (n = 561) and lung SCC (n = 523) RNA-Seq datasets.

Results: We identified 33 significantly deregulated miRNAs (fold change, FC ≥ 2.0 and p < 0.05) in tumors relative to normal lung tissues, regardless of tumor histology. Enrichment analysis confirmed that genes targeted by the 33 miRNAs are aberrantly expressed in lung AD and SCC, and modulate known pathways in lung cancer. Additionally, high expression of miR-25-3p was significantly associated (p < 0.05) with poor patient survival, when considering both tumor histologies.

Conclusions: miR-25-3p may be a potential prognostic biomarker in non-small cell lung cancer. Genes targeted by miRNAs regulate EGFR and TGFβ signaling, among other known pathways relevant to lung tumorigenesis.

 

FOS-B Human Recombinant Protein

PROTP53539 Regular: 5ug
EUR 574.8
Description: FOS-B Human Recombinant (a.a. 113-151) expressed in E.coli, shows a 32 kDa SDS-PAGE (Including GST).;The FOS-B is purified by proprietary chromatographic techniques.

Recombinant (E.Coli, GST) Human FOS-B

RP-945 2 ug
EUR 416.4

FOS B antibody

29246-100ul 100ul
EUR 302.4

Fos B Rabbit pAb

E2381043 100ul
EUR 225
Description: Available in various conjugation types.

Fos B Rabbit mAb

A24339 200μL
EUR 323.7
Description: A synthetic peptide corresponding to a sequence within amino acids 371-470 of human Desmin (P17661).

FOS B Conjugated Antibody

C29246 100ul
EUR 476.4

Fos B Polyclonal Antibody

ABP51360-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody

ABP51360-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody

ABP51360-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Fos B from Human, Mouse, Monkey. This Fos B antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the non-phosphorylation site of S27

Fos B Polyclonal Antibody

ES2359-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against Fos B from Human/Mouse/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B Polyclonal Antibody

ES2359-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against Fos B from Human/Mouse/Monkey. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B Polyclonal Antibody

E20-71738 100ug
EUR 225
Description: Available in various conjugation types.

Human Proto- oncogene c- Fos, FOS ELISA KIT

ELI-04266h 96 Tests
EUR 988.8

Recombinant Human FOS-B Protein, Untagged, E.coli-2ug

QP11898-2ug 2ug
EUR 294

Recombinant Human FOS-B Protein, Untagged, E.coli-5ug

QP11898-5ug 5ug
EUR 403.2

Recombinant Human FOS-B Protein, Untagged, E.coli-10ug

QP11898-10ug 10ug
EUR 663.6

Anti-Fos B/FOSB Antibody

PA1478 100ug/vial
EUR 352.8

Anti-Fos B/FOSB Antibody

RP1086 100ug/vial
EUR 400.8

Human FOS ELISA Kit

ELA-E1291h 96 Tests
EUR 988.8

FOS ELISA KIT|Human

EF005100 96 Tests
EUR 826.8

Human FOS ELISA Kit

EHF0120 96Tests
EUR 625.2

Human FOS ELISA Kit

IHUFOSKT each
EUR 548
Description: Human FOS ELISA Kit

Human Proto-Oncogene C-Fos (FOS) CLIA Kit

20-abx492601
  • EUR 9567.60
  • EUR 5095.20
  • EUR 1177.20
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Proto-Oncogene C-Fos (FOS) ELISA Kit

20-abx151580
  • EUR 8534.40
  • EUR 4550.40
  • EUR 1054.80
  • 10 × 96 tests
  • 5 × 96 tests
  • 96 tests

Human Proto-oncogene c-Fos (FOS) ELISA Kit

abx570165-96tests 96 tests
EUR 801.6

Human FOS/ Proto-oncogene c-Fos ELISA Kit

E0936Hu 1 Kit
EUR 685.2

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EH1465 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Human Proto-oncogene c-Fos (FOS) ELISA Kit

RK07956 96T
EUR 280

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EKF58552-48T 48T
EUR 396.9

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EKF58552-5x96T 5x96T
EUR 2693.25

Human FOS(Proto-oncogene c-Fos) ELISA Kit

EKF58552-96T 96T
EUR 567

Human FOS shRNA Plasmid

20-abx951644
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

FOS Recombinant Protein (Human)

RP012430 100 ug Ask for price

Human c Fos ELISA kit

E01C0735-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human c Fos ELISA kit

E01C0735-48 1 plate of 48 wells
EUR 624
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human c Fos ELISA kit

E01C0735-96 1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human c Fos in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

FOS ORF Vector (Human) (pORF)

ORF004144 1.0 ug DNA
EUR 114

Fos B (phospho Ser27) Polyclonal Antibody

ABP54356-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody

ABP54356-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody

ABP54356-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of Fos B phospho Ser27) from Human, Mouse. This Fos B phospho Ser27) antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Fos B around the phosphorylation site of S27

Fos B (phospho Ser27) Polyclonal Antibody

ES5355-100ul 100ul
EUR 334.8
Description: A Rabbit Polyclonal antibody against Fos B (phospho Ser27) from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B (phospho Ser27) Polyclonal Antibody

ES5355-50ul 50ul
EUR 248.4
Description: A Rabbit Polyclonal antibody against Fos B (phospho Ser27) from Human/Mouse. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA

Fos B (phospho Ser27) Polyclonal Antibody

E20-61178 100ug
EUR 225
Description: Available in various conjugation types.

Fos B (phospho Ser27) Polyclonal Antibody

E013857 100μg/100μl
EUR 255
Description: Available in various conjugation types.

FOS ELISA Kit (Human) (OKDD00273)

OKDD00273 96 Wells
EUR 1107.6
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ;Assay info: Quantitative Sandwich ELISA;Sensitivity: < 0.064 ng/mL

FOS ELISA Kit (Human) (OKCD07290)

OKCD07290 96 Wells
EUR 1123.2
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.054ng/mL

FOS ELISA Kit (Human) (OKEH04574)

OKEH04574 96 Wells
EUR 1216.8
Description: Description of target: The Fos gene family consists of 4 members: FOS, FOSB, FOSL1, and FOSL2. These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, thereby forming the transcription factor complex AP-1. As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation. In some cases, expression of the FOS gene has also been associated with apoptotic cell death.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.12 ng/mL

Human FOS Protein Lysate 20ug

IHUFOSPLLY20UG each
EUR 213
Description: Human FOS Protein Lysate 20ug

Human Fos-related antigen 2 (FOSL2)

1-CSB-EP008793HU
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Fos-related antigen 2(FOSL2) expressed in E.coli

anti-Fos B

YF-PA23732 50 ul
EUR 400.8
Description: Mouse polyclonal to Fos B

anti-Fos B

YF-PA11841 50 ul
EUR 435.6
Description: Mouse polyclonal to Fos B

anti-Fos B

YF-PA11842 50 ug
EUR 435.6
Description: Mouse polyclonal to Fos B

anti-Fos B

YF-PA11843 100 ul
EUR 483.6
Description: Rabbit polyclonal to Fos B

anti-Fos B

YF-PA11844 100 ug
EUR 483.6
Description: Rabbit polyclonal to Fos B

Human FOS Like Antigen 1 (FOSL1) Protein

20-abx066690
  • EUR 878.40
  • EUR 343.20
  • EUR 2732.40
  • EUR 1045.20
  • EUR 627.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

FOS sgRNA CRISPR Lentivector set (Human)

K0794201 3 x 1.0 ug
EUR 406.8

FOS siRNA

20-abx917079
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

FOS siRNA

20-abx917080
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

FOS siRNA

20-abx902000
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Human V-Fos FBJ Murine Osteosarcoma Viral Oncogene Homolog (FOS) Protein

20-abx166659
  • EUR 794.40
  • EUR 326.40
  • EUR 2448.00
  • EUR 944.40
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Human FOS Like Antigen 1 (FOSL1) ELISA Kit

abx384927-96tests 96 tests
EUR 1093.2

Human FOS Like Antigen 2 (FOSL2) ELISA Kit

abx387396-96tests 96 tests
EUR 1093.2

Human FOS-like antigen 2 (fosl2) ELISA Kit

YLA3890HU-48T 48T
EUR 435

Human FOS-like antigen 2 (fosl2) ELISA Kit

YLA3890HU-96T 96T
EUR 562.5

FOS antibody

10R-1389 100 ug
EUR 614.4
Description: Mouse monoclonal FOS antibody

FOS Antibody

29093-100ul 100ul
EUR 302.4

Fos antibody

70R-31126 100 ug
EUR 392.4
Description: Rabbit polyclonal Fos antibody

FOS antibody

70R-31287 100 ug
EUR 392.4
Description: Rabbit polyclonal FOS antibody

FOS antibody

70R-34384 100 ug
EUR 392.4
Description: Rabbit polyclonal FOS antibody

FOS antibody

70R-34398 100 ug
EUR 392.4
Description: Rabbit polyclonal FOS antibody

Fos antibody

70R-34513 100 ug
EUR 392.4
Description: Rabbit polyclonal Fos antibody

Fos Antibody

33336-100ul 100ul
EUR 302.4

Fos Antibody

33336-50ul 50ul
EUR 224.4

FOS Antibody

32032-100ul 100ul
EUR 302.4

FOS Antibody

ABD6039 100 ug
EUR 525.6

Fos Antibody

ABF0132 100 ug
EUR 525.6

Fos Antibody

ABF5354 100 ug
EUR 525.6

Fos Antibody

ABF6053 100 ug
EUR 525.6

FOS Antibody

CSB-PA138717- each
EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody

CSB-PA138717-100ul 100ul
EUR 376.8
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody

CSB-PA042478- each
EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

FOS Antibody

CSB-PA042478-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:1000

FOS Antibody

1-CSB-PA191502
  • EUR 380.40
  • EUR 292.80
  • 100ul
  • 50ul
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody

CSB-PA292648- each
EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

FOS Antibody

CSB-PA292648-100ul 100ul
EUR 379.2
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

FOS Antibody

1-CSB-PA008385
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

FOS Antibody

CSB-PA008790KA01HU- each
EUR 402
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody

CSB-PA008790KA01HU-100ul 100ul
EUR 466.8
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:2000, IHC:1:50-1:200

FOS Antibody

1-CSB-PA000378
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB;WB:1:1000-2000

FOS Antibody

1-CSB-PA001600
  • EUR 266.40
  • EUR 234.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against FOS. Recognizes FOS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000

Related Post